| Literature DB >> 26810710 |
Simone Carradori1, Daniela Secci2, Celeste De Monte3, Adriano Mollica1, Mariangela Ceruso4, Atilla Akdemir5, Anatoly P Sobolev6, Rossella Codispoti3, Federica De Cosmi3, Paolo Guglielmi3, Claudiu T Supuran7.
Abstract
Small libraries of N-substituted saccharin and N-/O-substituted acesulfame derivatives were synthesized and tested as atypical and selective inhibitors of four different isoforms of human carbonic anhydrase (hCA I, II, IX and XII, EC 4.2.1.1). Most of them inhibited hCA XII in the low nanomolar range, hCA IX with KIs ranging between 19 and 2482nM, whereas they were poorly active against hCA II (KIs >10μM) and hCA I (KIs ranging between 318nM and 50μM). Since hCA I and II are ubiquitous off-target isoforms, whereas the cancer-related isoforms hCA IX and XII were recently validated as drug targets, these results represent an encouraging achievement in the development of new anticancer candidates. Moreover, the lack of a classical zinc binding group in the structure of these inhibitors opens innovative, yet unexplored scenarios for different mechanisms of inhibition that could explain the high inhibitory selectivity. A computational approach has been carried out to further rationalize the biological data and to characterize the binding mode of some of these inhibitors.Entities:
Keywords: Acesulfame; Cancer-related isoforms; Carbonic anhydrase inhibitor; N/O-substitution; Saccharin
Mesh:
Substances:
Year: 2016 PMID: 26810710 DOI: 10.1016/j.bmc.2016.01.038
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641